Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to market the anticancer agent Halaven (eribulin... Read more
Singapore: Scientists of the RNL Stem Cell Technology Institute, Korea, transplanted own stem cells of patients suffering from Parry-Romberg syndrome, thus dramatically... Read more
Singapore: Varian Medical Systems, the world leader in radiotherapy and radiosurgery, is strengthening its leadership position in South Korea by establishing an... Read more
Bangalore: Seoul-based Ildong has received a marketing and manufacturing approval for idiopathic pulmonary fibrosis (IPF) treatment of Pirespa 200mg tablet. The... Read more
Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) with US-based Aquavit Pharmaceuticals for... Read more
Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of Erythropoietin (EPO) in Malaysia to treat... Read more
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF 723 - when taken up by a cell. The HGF has... Read more
Singapore: At a time when the issue of secondary infection is emerging as a big problem in many countries, South Korean medical device manufacturer Bosung Meditech... Read more
Singapore: Korea Food and Drug Administration (KFDA) has signed a memorandum of understanding (MoU) with National Agency of Drug and Food Control (NADFC) in Jakarta,... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
